Influence of Adrenergic Beta-receptor Blockade on the Acute Cardiovascular Effects of Hydralazine
Overview
Authors
Affiliations
EDMONSTONE W, Manghani K, Bell A, McLeod M, Burland W Br J Clin Pharmacol. 1981; 12(4):567-72.
PMID: 7295490 PMC: 1401881. DOI: 10.1111/j.1365-2125.1981.tb01266.x.
Nicholls D, Harron D, Shanks R Br J Clin Pharmacol. 1983; 15(1):21-9.
PMID: 6849740 PMC: 1427818. DOI: 10.1111/j.1365-2125.1983.tb01458.x.
The mechanism of the inhibitory action of adrenaline on the mammary gland.
Bisset G, Clark B, Lewis G Br J Pharmacol Chemother. 1967; 31(3):550-9.
PMID: 4384599 PMC: 1557334. DOI: 10.1111/j.1476-5381.1967.tb00419.x.
Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators.
Aenishanslin W, Dubach U, Imhof P, Turri M Eur J Clin Pharmacol. 1972; 4(3):177-81.
PMID: 4144064 DOI: 10.1007/BF00561142.
Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure.
Mulrow J, Crawford M Clin Pharmacokinet. 1989; 16(2):86-9.
PMID: 2656046 DOI: 10.2165/00003088-198916020-00003.